About this trial
This is a single-center prospective cohort study to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Controls: Adults above the age of 18.
Kidney stone patients: Adults above the age of 18.
History of majority (>50%) calcium oxalate kidney stones
Disqualifiers
Anyone with a history of calcium phosphate stones (>50% calcium phosphate), uric acid stones, struvite stones, recent urinary tract instrumentation (<30 days), or recurrent urinary tract infections.
Any individual who has had ACV outside of normal consumption in the prior month will be excluded.
Any individual who has a history of a negative reaction (increased acid reflux, allergy) to ACV will also be excluded.
Any individual with chronic kidney disease, underlying acid base disorder will also be excluded.
Trial design
Single group
Treatments tested in this trial
Apple Cider Vinegar
Dietary supplementGoli Apple Cider Vinegar gummies
Treatment groups
Trial outcomes
Primary outcomes
Measure changes in citrate in urine.
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Measure changes in Urine PH
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Measure changes in calcium in urine.
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Measure changes in calcium oxalate in urine
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: